Patents Assigned to ULTRAHUMAN NINE LIMITED
  • PD1 binding agents
    Patent number: 10858435
    Abstract: Provided herein are antibody molecules that bind specifically to Programmed cell death 1 (PD1) and related nucleic acid molecules, vectors and host cells. Also provided herein are medical uses of such antibody molecules.
    Type: Grant
    Filed: June 25, 2020
    Date of Patent: December 8, 2020
    Assignee: ULTRAHUMAN NINE LIMITED
    Inventor: William James Jonathan Finlay